Israel Englander’s Astria Therapeutics ATXS Stock Holding History

Israel Englander’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,200	Closed	-$622K	–	5866
2024 Q1	$622K	Buy	+44,200	New	+$550K	﹤0.01%	4668

Israel Englander's ATXS Position: Q1 2026 in Review

Israel Englander sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 534,054 shares — an estimated $6.99M sold.

Israel Englander first reported a position in ATXS in Q2 2015 and held it in 27 quarters. The position peaked at $27.4M in Q3 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Israel Englander reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Israel Englander sold 534,054 Astria Therapeutics shares in Q1 2026, an estimated $6.99M.
Israel Englander first reported a position in Astria Therapeutics in Q2 2015 and held it in 27 quarters.
Israel Englander's Astria Therapeutics position peaked at $27.4M in Q3 2024.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.